ArticleJAMA dermatology2022

Treatment Outcomes Associated With Dupilumab Use in Patients With Atopic Dermatitis: 1-Year Results From the RELIEVE-AD Study.

Bruce Strober et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.